
The average Vertex Pharmaceuticals Investor Relations earns an estimated $83,703 annually. Vertex Pharmaceuticals' Investor Relations compensation is $1,772 more than the US average for a Investor Relations.
Last updated 2 months ago.
The majority of Investor Relations at Vertex Pharmaceuticals believe they're compensated fairly. 100% of Investor Relations at Vertex Pharmaceuticals say they receive annual bonuses, and the vast majority (97%) are satisfied with their benefits. See more compensation ratings at Vertex Pharmaceuticals